Bristows has a world-class reputation for representing clients in this dynamic sector which is at the forefront of change brought on by the convergence of science and technology.  We can offer a breadth of multidisciplinary legal skills for clients ranging from multinational pharmaceutical and medical device companies to university and technology start-ups.

From bespoke laboratory buildings through to campus collaborations and technology clusters, our experienced real estate team works at finding the right solution for our clients.  We provide sensible, commercial and innovative advice on acquisitions and disposals through to the process of releasing capital by disposal of surplus property for redevelopment and everything in between.

Through our extensive industry knowledge and understanding of the unique workplace requirements of this sector we can pride ourselves on our ability to provide strategic support and guidance to clients at all stages of their business lifecycle enabling the organisation to focus on making the right operational decisions.

Key contact

Teresa Edmund

Contact

Experience

Advising on the real estate aspects relating to the provision of a sequencing centre for the analysis of DNA as part of a commercial contract to deliver the high profile, government backed, ‘100,000 Genomes Project’- the biggest project of its kind in the world

Acting for a global research-based bio-pharmaceutical company on the disposal of a UK manufacturing facility as part of a business disposal to a US operator

Acting on behalf of a medical technology company on its acquisition and complex fit out of new premises on a business park and a subsequent lease restructuring to provide offices, laboratory and a research and development facility

Advising a science driven contract research organisation developing preclinical and early phase formulations and the manufacture of clinical trials materials on its investment in new facilities

Advising an AIM listed company providing clinical trials services and technology on its property holding and business relocation

Advising on the real estate aspects of a joint venture for the development of new diagnostic tools between a specialist medical diagnostics company and a leading university

Latest articles

What others say

“The ‘highly responsive, commercial’ Marek Petecki is a ‘standout partner’ who ‘finds and communicates practicable solutions to issues, and tailors his work carefully’; he is noted for his strength in M&A involving IP and technology. Petecki’s highlights included advising AstraZeneca on the £135m sale of its pharmaceutical manufacturing facility in Avonmouth to Avara, and assisted Diageo with its acquisition of a stake in a joint venture established by Piers Adam to develop a new whisky brand.”

Legal 500 2017

“The ‘partner-led’ practice group at Bristows LLP has ‘good expertise in the area of partnership’, acting for investment partnerships and professional partnerships. Joint department head Iain Redford specialises in investment partnerships and also has particular expertise in refinancing partnerships. In 2016, he acted for multiple individual members in relation to the sale of their LLP.”

Legal 500 2017

“Commended for its ‘excellent service’ and ‘good value for money’, Bristows LLP’s department is strong in the TMT and life sciences sectors; it also has notable experience in the consumer goods space.”

Legal 500 2017

“Life sciences expert Mark Hawes, who heads the group, acted for Albireo on its NASDAQ listing and its $200m reverse merger with Biodel.”

Legal 500 2017

“Corporate partners Mark Hawes and Marek Petecki…are recommended” in the Pharmaceuticals and biotechnology sector.”

Legal 500 2017

Recent rankings and awards

Real Estate: Commercial property - General / Investment 
Legal 500 2017

Real Estate: Lower Mid-Market (London) - Noted Firm
Chambers and Partners 2015